Related Experiment Video

Updated: Mar 31, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

The role of HOXB2 and HOXB3 in acute myeloid leukemia

Oscar Lindblad1, Rohit A Chougule2, Sausan A Moharram2

  • 1Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden; Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden; Department of Hematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden.

Biochemical and Biophysical Research Communications
|October 21, 2015
PubMed

Insights

New research identifies HOXB2 and HOXB3 as novel tumor suppressors in Acute Myeloid Leukemia (AML) with FLT3-ITD mutations. These genes reduce cancer cell growth and promote cell death, offering potential new therapeutic targets for FLT3-driven AML.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Acute Myeloid Leukemia (AML) is an aggressive blood cancer, with FLT3 mutations present in over 30% of cases.
  • Current FLT3 inhibitors lack specificity and efficacy, leading to treatment resistance.
  • Understanding FLT3 signaling is crucial for identifying new therapeutic strategies in FLT3-driven AML.

Purpose of the Study:

  • To identify novel regulators of FLT3-ITD driven AML.
  • To investigate the role of HOXB2 and HOXB3 in FLT3-ITD positive AML.

Main Methods:

  • Analysis of HOXB2 and HOXB3 expression in AML patient samples with FLT3-ITD.
  • Overexpression of HOXB2 or HOXB3 in mouse pro-B cells.
  • Assessment of cell proliferation, colony formation, apoptosis, and signaling pathway phosphorylation (AKT, ERK, p38, STAT5).

Main Results:

  • HOXB2 and HOXB3 expression is upregulated in a subset of AML patients with FLT3-ITD.
  • Overexpression of HOXB2 or HOXB3 suppressed FLT3-ITD-dependent cell proliferation and colony formation.
  • HOXB2 and HOXB3 overexpression increased apoptosis and reduced FLT3-ITD-induced phosphorylation of key signaling proteins.

Conclusions:

  • HOXB2 and HOXB3 act as tumor suppressors in FLT3-ITD driven AML.
  • These findings highlight HOXB2 and HOXB3 as potential therapeutic targets for FLT3-mutated AML.
  • Further research into HOXB2 and HOXB3 could lead to more specific and effective AML treatments.
Keywords:
Acute myeloid leukemiaColony formationFLT3HOXB2HOXB3STAT5

More Related Videos

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

8.9K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.6K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.4K